Table: Phoenixbio -2019/20 group results

PhoenixBio

22/05/2020 07:30

May 22 (Reuters)- 
          Phoenixbio Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended       Year ended       Year to       NEXT   
               Mar 31, 2020     Mar 31, 2019   Mar 31, 2021     YEAR     
                  LATEST          YEAR-AGO        COMPANY      COMPANY   
                 RESULTS          RESULTS        FORECAST    H1 FORECAST 
  Sales            1.31             1.23                                 
                (+6.7 pct)      (+36.1 pct)                              
  Operating    loss 146 mln     loss 311 mln                             
  Recurring    loss 125 mln     loss 279 mln                             
  Net
  Net          loss 415 mln     loss 297 mln                             
  EPS        loss 141.84 yen  loss 101.96 yen                            
  Ann Div          NIL              NIL             NIL                  
  -Q2 Div          NIL              NIL             NIL                  
  -Q4 Div          NIL              NIL             NIL                  
  
  NOTE - Phoenixbio Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T